Skip to Content
Merck
CN
  • Biotin-responsive basal ganglia disease: case report and review of the literature.

Biotin-responsive basal ganglia disease: case report and review of the literature.

Neuropediatrics (2009-03-19)
T I El-Hajj, P E Karam, M A Mikati
ABSTRACT

Biotin-responsive basal ganglia disease is a rare entity of which 10 cases have been reported in the literature. We report a case of biotin-responsive basal ganglia disease with similarities and differences compared to the previously reported cases by Ozand et al. Our case presented much earlier, was milder and responded better to lower doses of biotin, compared to the cases reported previously. Since our case showed differences with those in the literature, it might represent a new entity or a milder form of the same entity.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Biotin, ≥99.0% (T)
Sigma-Aldrich
Biotin, tested according to Ph. Eur.
Sigma-Aldrich
Biotin, powder, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥99%
Sigma-Aldrich
Biotin, meets USP testing specifications
Supelco
Biotin, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
USP
Biotin, United States Pharmacopeia (USP) Reference Standard
Biotin, European Pharmacopoeia (EP) Reference Standard
SAFC
BIOTIN
Supelco
Biotin, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Biotin, Vetec, reagent grade, ≥99%